Table 3.
Comparison between patient and control groups regarding demographic, clinical and laboratory parameters
| Variables | Controls Mean±SD |
Patients Mean±SD |
t-value | p-value | Sig. |
|---|---|---|---|---|---|
| Age (years) | 14.50±2.87 | 14.32±2.27 | 0.18 | >0.05 | NS |
| MIO (mm) | 53.33±1.11 | 43.0±4.93 | 6.1 | <0.001 | HS |
| Neut. Count (× 109 mL−1) |
4.91±0.65 | 5.24±0.52 | 1.5 | >0.05 | NS |
| Hb (g dL−1) | 13.05±1.33 | 10.62±0.90 | 5.8 | <0.001 | HS |
| ESR (mm h−1) | 7.5±2.59 | 61.30±37.11 | 4.5 | <0.001 | HS |
| Serum S100A12 (ng mL−1) |
81.5±27.99 | 666.0±391.3 | 4.6 | <0.001 | HS |
MIO: Maximal interincisal opening, Neut: Neutrophil, Hb: Haemoglobin, ESR: Erythrocyte sedimentation rate. There were high significant differences between both groups regarding maximal interincisal opening and serum S100A12 levels. NS: Not significant, HS: Highly significant